Calamos Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.2M Buy
602,965
+25,128
+4% +$2.41M 0.19% 123
2025
Q4
$55.5M Buy
577,837
+39,819
+7% +$3.87M 0.21% 116
2025
Q3
$51.2M Buy
538,018
+117,358
+28% +$10.8M 0.19% 121
2025
Q2
$36.7M Buy
420,660
+178
+0% +$15.1K 0.14% 165
2025
Q1
$37.8M Sell
420,482
-115,894
-22% -$10.4M 0.16% 149
2024
Q4
$42.8M Buy
536,376
+572
+0.1% +$49.5K 0.18% 129
2024
Q3
$48.2M Sell
535,804
-4,732
-0.9% -$398K 0.21% 115
2024
Q2
$42.5M Sell
540,536
-8,845
-2% -$725K 0.19% 120
2024
Q1
$47.9M Sell
549,381
-18,813
-3% -$1.61M 0.23% 109
2023
Q4
$46.8M Sell
568,194
-45,650
-7% -$3.48M 0.23% 114
2023
Q3
$48.1M Buy
613,844
+34,785
+6% +$2.91M 0.25% 102
2023
Q2
$51M Buy
579,059
+161,384
+39% +$13.9M 0.25% 97
2023
Q1
$33.7M Sell
417,675
-36,395
-8% -$2.97M 0.16% 153
2022
Q4
$35.3M Sell
454,070
-57,879
-11% -$4.69M 0.17% 164
2022
Q3
$41.3M Buy
511,949
+234
+0% +$21K 0.19% 132
2022
Q2
$45.9M Sell
511,715
-49,603
-9% -$5.03M 0.2% 123
2022
Q1
$62.3M Buy
561,318
+50,375
+10% +$5.32M 0.23% 104
2021
Q4
$52.9M Sell
510,943
-6,778
-1% -$785K 0.2% 120
2021
Q3
$64.9M Buy
517,721
+55,870
+12% +$7.23M 0.28% 85
2021
Q2
$57.3M Buy
461,851
+69,263
+18% +$8.7M 0.26% 86
2021
Q1
$46.4M Buy
392,588
+5,975
+2% +$700K 0.25% 94
2020
Q4
$45.3M Sell
386,613
-10,181
-3% -$1.12M 0.26% 99
2020
Q3
$41.2M Sell
396,794
-20,975
-5% -$2.11M 0.27% 95
2020
Q2
$38.3M Sell
417,769
-153,687
-27% -$14.7M 0.27% 100
2020
Q1
$51.5M Sell
571,456
-258,683
-31% -$27.5M 0.4% 58
2019
Q4
$94.2M Sell
830,139
-18,426
-2% -$2.02M 0.47% 43
2019
Q3
$92.2M Sell
848,565
-310,256
-27% -$32.4M 0.5% 43
2019
Q2
$113M Buy
1,158,821
+60,305
+5% +$5.51M 0.63% 24
2019
Q1
$100M Buy
1,098,516
+212,467
+24% +$19M 0.62% 25
2018
Q4
$80.6M Buy
886,049
+396,320
+81% +$37M 0.53% 39
2018
Q3
$48.2M Buy
489,729
+107,727
+28% +$9.96M 0.27% 99
2018
Q2
$32.7M Buy
382,002
+38,849
+11% +$3.24M 0.2% 137
2018
Q1
$27.5M Buy
343,153
+6,256
+2% +$516K 0.18% 161
2017
Q4
$27.2M Sell
336,897
-44,721
-12% -$3.58M 0.14% 163
2017
Q3
$29.7M Buy
381,618
+153
+0% +$12.7K 0.23% 133
2017
Q2
$33.9M Buy
381,465
+2,885
+0.8% +$243K 0.25% 117
2017
Q1
$30.5M Sell
378,580
-33,135
-8% -$2.59M 0.24% 119
2016
Q4
$29.3M Sell
411,715
-3,288
-0.8% -$258K 0.23% 129
2016
Q3
$35.9M Sell
415,003
-1,204
-0.3% -$105K 0.26% 123
2016
Q2
$36.1M Buy
416,207
+225,587
+118% +$18.2M 0.25% 126
2016
Q1
$14.3M Sell
190,620
-5,744
-3% -$433K 0.09% 229
2015
Q4
$15.1M Hold
196,364
0.1% 228
2015
Q3
$13.1M Sell
196,364
-17,510
-8% -$1.29M 0.09% 234
2015
Q2
$15.8M Sell
213,874
-88,084
-29% -$6.73M 0.1% 219
2015
Q1
$23.6M Sell
301,958
-27,545
-8% -$2.09M 0.15% 180
2014
Q4
$23.8M Sell
329,503
-12,402
-4% -$862K 0.16% 169
2014
Q3
$21.2M Buy
341,905
+54,761
+19% +$3.48M 0.14% 179
2014
Q2
$18.3M Buy
287,144
+155,144
+118% +$9.42M 0.12% 185
2014
Q1
$8.12M Hold
132,000
0.05% 265
2013
Q4
$7.58M Hold
132,000
0.05% 269
2013
Q3
$7.03M Hold
132,000
0.04% 266
2013
Q2
$6.79M Buy
+132,000
New +$6.52M 0.04% 251

Other funds holding MDT

Calamos Advisors's MDT Position: Q1 2026 in Review

Calamos Advisors increased its Medtronic (MDT) stake by 4.3% in Q1 2026, buying an estimated $2.41M and bringing the position to 602,965 shares worth $52.2M. The position accounts for 0.19% of the portfolio, ranked #123.

Calamos Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $113M in Q2 2019. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Calamos Advisors held 602,965 shares of Medtronic worth $52.2M as of Q1 2026.
  • Calamos Advisors bought 25,128 Medtronic shares in Q1 2026, an estimated $2.41M.
  • Medtronic made up 0.19% of Calamos Advisors's portfolio in Q1 2026, its #123 holding.
  • Calamos Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Calamos Advisors's Medtronic position peaked at $113M in Q2 2019.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.